Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amylin”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Post-approval studies (Phase 4)Study completedNCT00477581
What this trial is testing

Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 102
Large-scale testing (Phase 3)Study completedNCT00082407
What this trial is testing

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 505
Large-scale testing (Phase 3)Study completedNCT00676338
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 820
Testing effectiveness (Phase 2)Study completedNCT01104701
What this trial is testing

Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

Who this might be right for
Type 2 Diabetes
AstraZeneca 121
Large-scale testing (Phase 3)Study completedNCT00324363
What this trial is testing

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 466
Large-scale testing (Phase 3)Study completedNCT00765817
What this trial is testing

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
AstraZeneca 261
Large-scale testing (Phase 3)Study completedNCT00577824
What this trial is testing

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

Who this might be right for
Type 2 Diabetes
AstraZeneca 181
Early research (Phase 1)Not Yet RecruitingNCT07527195
What this trial is testing

Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)

Who this might be right for
Obesity
Novo Nordisk A/S 100
Large-scale testing (Phase 3)Study completedNCT00603239
What this trial is testing

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 165
Not applicableStudy completedNCT00229658
What this trial is testing

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
AstraZeneca 1,297
Early research (Phase 1)Study completedNCT01297062
What this trial is testing

A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects

Who this might be right for
Healthy Subjects
AstraZeneca 94
Not applicableStudy completedNCT00361946
What this trial is testing

The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).

Who this might be right for
Type 2 Diabetes
Baylor College of Medicine 45
Not applicableNot Yet RecruitingNCT07340775
What this trial is testing

Hypersensitivity to Amylin in Post-Traumatic Headache

Who this might be right for
Headache Disorders, SecondaryBrain DiseasesHeadache Disorders+14 more
Danish Headache Center 21
Early research (Phase 1)Study completedNCT00672399
What this trial is testing

Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects

Who this might be right for
Healthy Subjects
AstraZeneca 70
Large-scale testing (Phase 3)Study completedNCT00360334
What this trial is testing

A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 235
Testing effectiveness (Phase 2)Study completedNCT00099580
What this trial is testing

PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure

Who this might be right for
Congestive Heart Failure
AstraZeneca 61
Testing effectiveness (Phase 2)Study completedNCT00894322
What this trial is testing

Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 65
Large-scale testing (Phase 3)Study completedNCT01029886
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 912
Large-scale testing (Phase 3)Study completedNCT00434954
What this trial is testing

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 494
Testing effectiveness (Phase 2)Ended earlyNCT01235741
What this trial is testing

Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

Who this might be right for
Obesity
AstraZeneca 213
Load More Results